SCHOOL OF GRADUATE STUDIES & RESEARCH
Grand Challange – Low-Cost Monoclonal Antibody (mAb) Manufacturing
- DONOR: Bill & Melinda Gates Foundation
- Innovation
Grand Challange – Low-Cost Monoclonal Antibody (mAb) Manufacturing
REF: I-01
Support to development
Proposals to develop proof-of-concept for manufacturing platforms that produce monoclonal antibodies at a final drug substance cost-of-goods of $10 per gram (Option A)
- 31/1/2025
- Up to $750,000 USD for each project, with a grant term of up to 18 months.
- Priority collaboration with institutions based in low- and middle- income countries
- DONOR: Bill & Melinda Gates Foundation